Skip to Main content Skip to Navigation
Journal articles

Agomelatine: a new opportunity to reduce neuropathic pain. Preclinical evidence.

Complete list of metadata

https://hal.uca.fr/hal-01659567
Contributor : Emilie Clemencon Connect in order to contact the contributor
Submitted on : Friday, December 8, 2017 - 3:04:22 PM
Last modification on : Thursday, December 9, 2021 - 3:31:43 AM

Identifiers

Collections

Citation

Chouki Chenaf, Eric Chapuy, Frédéric Libert, Fabien Marchand, Christine Courteix, et al.. Agomelatine: a new opportunity to reduce neuropathic pain. Preclinical evidence.. PAIN, Elsevier, 2017, 158 (1), pp.149 - 160. ⟨10.1097/j.pain.0000000000000738⟩. ⟨hal-01659567⟩

Share

Metrics

Record views

207